Development of the method for determinating ADCC biological activity of IVIG

Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 2

Abstract

Objective To establish a method for determinating the antigen-dependent cell-mediated cytotoxicity (ADCC) of human immunoglobulin (pH4)for intravenous injection (IVIG) on luciferase reporter gene-modified cell assay. Methods As effector cells, Jurkat-NFAT-Luc-CD16 cells were used in the assay, and PLC/PRF/5 cells were used as target cells. After incubation of effector cells and target cells with IVIG, the method for determinating ADCC biological activity of IVIG was established by detecting luciferase released by activated T nuclear factor after binding of IVIG Fc fragment to effector cells. Meanwhile, the experimental assay conditions were optimized, and the methodology was verified subsequently. Results IVIG had a dose-response relationship in this method, which was consistent with four parameter logistic model. And the PLC/PRF/5 cells were finally determined as the target cells. The initial dilution concentration of antibody was 20 mg/mL, and the ratio dilution was 1∶2, and the effector to target ratio was 1∶3, and co-incubation time of two cells and IVIG was 24 hours. Within-run and between-run analysis including three independent tests, initial working concentration relative light unit (RLU) and the relative standard deviation (RSD) of the concentration for 50% of maximal effect(EC50) were less than 11%. The relative titers of the recovery samples of the two different dilution groups were (23.50±1.69)% and (49.30±2.97)%, respectively, and the corresponding recovery rates were (93.50±6.30)% and (96.24±5.43)%, respectively, with RSD less than 11%. Conclusion The method for determinating ADCC biological activity of IVIG based on luciferase reporter gene-modified cell assay was successfully established. It could be applied in determinating the ADCC biological activity of IVIG, and has the advantages of satisfactory linearity, accuracy, precision and specificity.

Authors and Affiliations

Liyuan ZHU, Qing LIU, Li MA, Changqing LI

Keywords

Related Articles

Hematopoietic regulation of transcription factor GATA1 and mutations causing hereditary erythroid and megakaryocytic disorders

GATA-binding protein 1 (GATA1), an important hematopoietic transcription factor, specifically regulates the proliferation and differentiation of erythroid and megakaryoid cells at the transcription level, which maintains...

Desalination effect on FⅧ components: a compartive study among 5 desalination methods

Objective To compare the desalination effects of five desalination methods and their effects on the components for human coagulation factor Ⅷ(FⅧ), and provide reference for selection of protein desalination methods. Meth...

HBV serologic and virus characteristics of HBsAg negative and NAT non-discriminated samples from blood donors

Objective To investigate the HBV infection of TMA initially reactive but discriminatory test non-reactive samples(NDR) after the individual donation nucleic acid detection(ID-NAT)of TMA, and analyze its serological and m...

Clinical manifestations and genetic mutation analysis of 20 patients with congenital Fibrinogen disorders

Objective To retrospectively analyze the clinical manifestations, related laboratory examinations and gene mutation of 20 patients with congenital Fibrinogen disorders (CFD) admitted to our hospital from February 2017 to...

Efficacy of autologous ozoneized blood transfusion in improving motor function in convalescent stroke patients

Objective To investigate the efficacy of autologous ozoneized blood transfusion(AOBT) in improving consciousness and motor function in convalescent stroke patients. Methods A total of 44 patients who were diagnosed as co...

Download PDF file
  • EP ID EP738481
  • DOI 10.13303/j.cjbt.issn.1004-549x.2023.02.007
  • Views 57
  • Downloads 0

How To Cite

Liyuan ZHU, Qing LIU, Li MA, Changqing LI (2023). Development of the method for determinating ADCC biological activity of IVIG. Chinese Journal of Blood Transfusion, 36(2), -. https://www.europub.co.uk/articles/-A-738481